US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.65

+1.252.01%

Volume:4K

Turnover:264.60K

Market Cap:274.97M

PE:20.82

High:63.65

Open:63.03

Low:63.03

Close:62.40

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:0.52

T/O Rate:0.10%

Dividend:1.53

Dividend Rate:2.40%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Axsome Therapeutics Q2 EPS USD -0.99

THOMSON REUTERS

Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million

THOMSON REUTERS

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS

Roivant Sciences Ltd : Citigroup Raises Target Price to $46 from $42

THOMSON REUTERS

BeOne Medicines partners with Revolution Medicines for clinical development

BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal

Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets

THOMSON REUTERS

Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor

THOMSON REUTERS

Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region

THOMSON REUTERS

Revolution Medicines, Inc. : JP Morgan Raises Target Price to $227 from $205

THOMSON REUTERS

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.

Axsome Therapeutics (AXSM) Could Be 25% Undervalued As CNS Pipeline Hopes Build

Simply Wall St.

Huadong Medicine Subsidiary Secures EU MDR CE Certification for Medical Device

Analysts Are Bullish on These Healthcare Stocks: Spyre Therapeutics (SYRE), Revolution Medicines (RVMD)

RBC Capital Remains a Buy on GH Research (GHRS)

Axsome CEO Herriot Tabuteau Disposes of USD 10.54 Million in Common Shares

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

Roivant Sciences is Maintained at Buy by HC Wainwright & Co.

Roivant Sciences price target raised to $42 from $36 at Guggenheim

Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PTH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.6505,"timestamp":1787670148236,"preClose":62.3981,"halted":0,"volume":4167,"delay":0,"changeRate":0.02007112396050523,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Trading","change":1.2524,"latestTime":"08-25 11:04:29 EDT","open":63.03,"high":63.6507,"low":63.03,"amount":264598.2495,"amplitude":0.009947,"askPrice":63.73,"askSize":100,"bidPrice":63.59,"bidSize":800,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.3981,"sharesOutstanding":2480000,"nav":62.98271,"aum":273974788.5,"dividendRate":0.024019,"bidAskSpread":0.002049,"postHourTrading":{"tag":"盘后","latestPrice":62.41,"preClose":62.3981,"latestTime":"19:30 EDT","volume":14,"amount":872.8867,"timestamp":1787614203296,"change":0.0119,"changeRate":0.000191,"amplitude":0},"volumeRatio":0.520018,"impliedVol":0.1601,"impliedVolPercentile":0.7928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.520018,"shares":4320000,"dividePrice":1.5288,"high":63.6507,"amplitude":0.009947,"preClose":62.3981,"low":63.03,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.6505,"committee":0.777778,"eps":3.057033,"divideRate":0.024019,"volume":4167,"delay":0,"ttmEps":3.057033,"open":63.03,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":60.7585,"twentyDayClose":57.983,"sixtyDayClose":51.9608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658938554","title":"Axsome Therapeutics Q2 EPS USD -0.99","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938554?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4505","AXSM","BK4007","PTH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658777980","title":"Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658777980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658777980?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4505","AXSM","PTH","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658798005","title":"Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658798005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658798005?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA9MN6XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","LU2324357040.USD","BK4585","BK4505","BK4007","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658987522","title":"Roivant Sciences Ltd : Citigroup Raises Target Price to $46 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2658987522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658987522?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:15","pubTimestamp":1786356924,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ROIV","PTH","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658110987","title":"BeOne Medicines partners with Revolution Medicines for clinical development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658110987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658110987?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:15","pubTimestamp":1786356922,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) and Revolution Medicines (RVMD) announced a multi-part collaboration including: a clinical collaboration to evaluate drug com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-partners-with-revolution-medicines-for-clinical-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-partners-with-revolution-medicines-for-clinical-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","ONC","IE00BJT1NW94.SGD","BK4526","IDNA","RVMD","BK4588","CANC","IE0009354923.USD","BBH","LU0109394709.USD","IE00BJJMRZ35.SGD","PTH","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4139","IE0009355771.USD","BK4585","LU0320765992.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982220","title":"BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982220","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982220?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:01","pubTimestamp":1786356092,"startTime":"0","endTime":"0","summary":"BeOne Medicines teams with Revolution Medicines on RAS cancer drug development, Asia rights dealBeOne Medicines AG entered a multi-part collaboration with Revolution Medicines covering clinical develo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9VYymL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BBH","LU0889565916.HKD","CANC","IE00BJT1NW94.SGD","BK0239","BK4139","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE0009355771.USD","688235","PTH","IE00B4R5TH58.HKD","IE0009354923.USD","IE00BJJMRZ35.SGD","IDNA","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982475","title":"Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982475?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","PTH","IE0002141913.USD","IE00B4R5TH58.HKD","688235","IE0009355771.USD","LU0889565916.HKD","IDNA","IE00BJJMRZ35.SGD","BK0239","BBH","BK4139","IE00BJT1NW94.SGD","RVMD","CANC","IE0009354923.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982449","title":"Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982449?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","BBH","688235","IE00BJJMRZ35.SGD","LU0109394709.USD","BK0239","LU0889565916.HKD","IE0002141913.USD","BK4139","IDNA","IE00BFTCPJ56.SGD","IE0009354923.USD","IE0009355771.USD","PTH","LU0320765992.SGD","IE00BJT1NW94.SGD","CANC","RVMD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658296982","title":"Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2658296982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658296982?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","688235","PTH","BBH","IDNA","IE0009354923.USD","IE0002141913.USD","LU0320765992.SGD","CANC","BK0239","LU0889565916.HKD","LU0109394709.USD","IE00B2B36J28.USD","RVMD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658006076","title":"Revolution Medicines, Inc. : JP Morgan Raises Target Price to $227 from $205","url":"https://stock-news.laohu8.com/highlight/detail?id=2658006076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658006076?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:04","pubTimestamp":1786341899,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN447095:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVMD","LU0889565916.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","CANC","PTH","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","IDNA","BBH","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0009354923.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658660616","title":"Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658660616","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658660616?lang=en_us&edition=fundamental","pubTime":"2026-08-10 07:38","pubTimestamp":1786318701,"startTime":"0","endTime":"0","summary":"GH Research PLC recently reported second-quarter 2026 results showing a net loss of US$15.15 million, up from US$9.29 million a year earlier, with basic and diluted loss per share from continuing operations rising to US$0.23 from US$0.15.\nFor the first half of 2026, the company’s net loss expanded to US$34.11 million versus US$20.10 million in the prior-year period, highlighting a meaningful increase in cash burn and pressure on its financial profile.\nWe’ll now examine how this widening net...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/is-gh-researchs-rising-loss-per-share-reframing-the-ghrs-cas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/is-gh-researchs-rising-loss-per-share-reframing-the-ghrs-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GH","LU0109394709.USD","BK4007","EKG","FFOX","BK4535","BK4551","PTH","LU0889565916.HKD","GNMX","LFSC","GDOC","GNOM","HELX","BK4539","PSIL","LU0320765992.SGD","BK4196","BK4585","GHRS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658606133","title":"Axsome Therapeutics (AXSM) Could Be 25% Undervalued As CNS Pipeline Hopes Build","url":"https://stock-news.laohu8.com/highlight/detail?id=2658606133","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658606133?lang=en_us&edition=fundamental","pubTime":"2026-08-10 07:35","pubTimestamp":1786318507,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics event context and recent stock performance\nAxsome Therapeutics (AXSM) continues to draw investor attention as it advances therapies for central nervous system disorders, including approved treatments for depression, excessive daytime sleepiness, and migraine, alongside multiple late stage clinical programs.\nThe stock last closed at US$212.74 on 7 August 2026. Over the past month the share price declined 9%, while the past 3 months show a smaller fall of 1.7%, leaving the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-therapeutics-axsm-could-be-25-undervalued-as-cns-pipe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-therapeutics-axsm-could-be-25-undervalued-as-cns-pipe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CNS","AXSM","LU2324357040.USD","PTH","BK4505","BK4135","BGSX","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145023735","title":"Huadong Medicine Subsidiary Secures EU MDR CE Certification for Medical Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1145023735","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145023735?lang=en_us&edition=fundamental","pubTime":"2026-08-09 16:40","pubTimestamp":1786264814,"startTime":"0","endTime":"0","summary":"Huadong Medicine Co.,Ltd. (000963.SZ) announced that its wholly-owned UK subsidiary, Sinclair Pharma Limited (\"Sinclair\"), has obtained EU MDR CE certification for KIO015, a novel injectable...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDEV","GDOC","LU2328871848.SGD","BK0132","BK4585","HART","PTH","LNGR","BK0175","CE","BK4588","IEIH","AGNG","BK1574","BK1100","BK0188","LGHT","BK1583","BK0209","BK0196","PSCM","MEDX","BK0187","FSXEmain","BK0183","09996","BK4109","LU1969619763.USD","000963","RSPH","159883","FESXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567890","title":"Analysts Are Bullish on These Healthcare Stocks: Spyre Therapeutics (SYRE), Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567890?lang=en_us&edition=fundamental","pubTime":"2026-08-08 22:40","pubTimestamp":1786200025,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and Revolution Medicines (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-spyre-therapeutics-syre-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-spyre-therapeutics-syre-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","PTH","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","BBH","RVMD","LU0109394709.USD","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","IE0009354923.USD","IE00BJT1NW94.SGD","IDNA","SYRE","LFSC","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657229326","title":"RBC Capital Remains a Buy on GH Research (GHRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657229326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657229326?lang=en_us&edition=fundamental","pubTime":"2026-08-08 09:45","pubTimestamp":1786153544,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Buy rating on GH Research on August 6 and set a price target of $42.00. The company’s shares closed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-gh-research-ghrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-gh-research-ghrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GSIB","LU0128525929.USD","PTH","BK4207","GNMX","GDOC","BK4551","LU0310800379.SGD","LU1267930573.SGD","PSIL","BK4535","LU0889565916.HKD","GHRS","EKG","LU0708994859.HKD","GH","LU0029864427.USD","GNOM","HELX","LU0109394709.USD","BK4196","LFSC","LU0320765992.SGD","BK4007","BK4539","FFOX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621762","title":"Axsome CEO Herriot Tabuteau Disposes of USD 10.54 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621762","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621762?lang=en_us&edition=fundamental","pubTime":"2026-08-08 07:00","pubTimestamp":1786143638,"startTime":"0","endTime":"0","summary":"Axsome CEO Herriot Tabuteau disposes of USD 10.54 million in common sharesAxsome Therapeutics CEO Herriot Tabuteau sold 49,664 shares on Aug. 5-6 at weighted average prices of $212.01 and $213.95.Sale","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLc4nn64:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Axsome CEO Herriot Tabuteau Disposes of USD 10.54 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4505","BK4007","LU2324357040.USD","PTH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657260426","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657260426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657260426?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:30","pubTimestamp":1786134613,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD), GH Research (GHRS) and Scholar Rock...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BK4139","BK4581","IBRN","BK4196","LABU","GH","GNOM","PSIL","SRRK","GNMX","LU0109394709.USD","PTH","LFSC","GDOC","XLV","LU0889565916.HKD","INMD","LU0320765992.SGD","HELX","BK4535","HCSG","EKG","LU0128526141.USD","BK4585","FFOX","BK4082","XBI","BK4551","BK4137","THNR","BK4007","GHRS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657499136","title":"Roivant Sciences is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657499136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657499136?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:22","pubTimestamp":1786108920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PTH","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648299","title":"Roivant Sciences price target raised to $42 from $36 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648299?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:41","pubTimestamp":1786102901,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Roivant Sciences (ROIV) to $42 from $36 and keeps a Buy rating on the shares. Published first on TheFl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-42-from-36-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-42-from-36-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","ROIV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657612511","title":"Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2657612511","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657612511?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:18","pubTimestamp":1786097924,"startTime":"0","endTime":"0","summary":"BRIEF-Alphabet Reports Share Stake In SpaceX, Fervo Energy And Parabilis MedicinesAug 7 (Reuters)-Alphabet Inc.GOOGL.O:ALPHABET INC. REPORTS SHARE STAKE OF 551.2 MILLION CLASS A SHARES IN SPACEX - SEC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4432E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999017495.SGD","IE0004086264.USD","LU1235294995.USD","LU2860962120.EUR","LU1852331112.SGD","LU1868836591.USD","LU2168564149.EUR","LU0312595415.SGD","BK4588","LU2404859741.USD","LU2462157665.USD","LU1699723380.USD","SG9999015358.SGD","IE00BYXW3230.USD","LU2065171402.SGD","LU0029864427.USD","HK0000304797.USD","LU1951198990.SGD","IE00BQXX3F31.USD","BK4561","LU2168563687.JPY","LU0211326839.USD","LU2362540622.SGD","LU0211326755.USD","LU0545039389.USD","LU0348723411.USD","LU2420271590.USD","LU0211328371.USD","LU1720051017.SGD","LU2430703251.USD","LU0198837287.USD","LU0345768740.USD","LU1059921491.USD","LU0784383803.USD","LU2381873111.SGD","SGXZ31699556.SGD","IE00BJTD4N35.SGD","IE00B1BXHZ80.USD","LU1551013425.SGD","LU2111349929.HKD","LU0124676726.USD","LU0061474960.USD","LU0889565916.HKD","IE0034235295.USD","LU0323591593.USD","LU1116320737.USD","LU2264538146.SGD","LU2250418816.HKD","LU2213496289.HKD","LU0942090050.USD","LU2125909593.SGD","IE00BN8TJ469.HKD","LU0823421333.USD","SG9999000418.SGD","BK4514","LU1585245621.USD","LU2275660780.HKD","LU1720051108.HKD","LU0557290698.USD","LU2089284900.SGD","LU0094547139.USD","LU2125909247.SGD","LU1935042991.SGD","LU1989764748.USD","LU0823434583.USD","BK4598","LU0109391861.USD","IE0009355771.USD","IE00BK4W5M84.HKD","LU0642271901.SGD","SG9999018857.SGD","HK0000819398.USD","LU2471134796.USD","LU1261432733.SGD","LU0426417589.USD","LU2098885051.SGD","LU1267930490.SGD","LU2106854487.HKD","LU0476273544.USD","LU0345768153.USD","LU1935043536.SGD","LU0354030438.USD","SG9999018865.SGD","BK4602","IE00BJTD4V19.USD","LU1221951046.USD","IE00BMPRXN33.USD","LU2087625088.SGD","HK0000304805.HKD","LU0158827948.USD","LU1645745479.HKD","LU0980610538.SGD","IE0000B7K699.USD","LU0738911758.USD","LU2023250504.SGD","OGIG","IE00BSNM7G36.USD","LU0052756011.USD","LU2954938101.SGD","LU2433249047.HKD","LU0792757196.USD","LU0267386448.USD","IE00BDRTCR15.USD","IE00BQXX3C00.GBP","LU1430594728.SGD","METV","LU2168564222.USD","LU0345769128.USD","LU1400636574.HKD","LU0689626769.HKD","LU2999663052.SGD","IE000SO60NU8.SGD","LU2265009873.SGD","LU2592432038.USD","GOOGL","LU1803068623.USD","LU2357305700.SGD","RVMD","LU0211331839.USD","PBLS","VOX","IE000F7OJYX1.SGD","BK4503","LU2244417387.USD","LU0949170772.SGD","LU2471134879.HKD","LU0823434740.USD","IE0009354923.USD","LU0354030511.USD","LU1301847155.USD","LU1003077747.HKD","BK4534","LU1153585028.USD","LU2092627202.USD","LU0466842654.USD","LU0957791311.USD","LU0234572021.USD","LU0130103400.USD","BK4527","LU0444973449.USD","LU0265550359.USD","LU1989764664.SGD","LU2237438978.USD","LU2360032135.SGD","BK4574","GOOP","LU0784385840.USD","LU2236285917.USD","LU0345774631.USD","LU0943347566.SGD","LU0130517989.USD","LU1267930813.SGD","LU0128525689.USD","SG9999014567.USD","LU2097829019.USD","GOOY","LU1894683264.USD","IE000WAW04H5.SGD","LU0690374615.EUR","LU1066051498.USD","IE00BJJMRZ35.SGD","SG9999015341.SGD","LU1196500208.SGD","LU1043141396.HKD","LU0426412945.USD","LU1066051811.HKD","LU1366192091.USD","LU1267930227.SGD","IE00BHPRN162.USD","BK4543","XDAT","LU0011850046.USD","LU0210533765.USD","LU1043141123.HKD","IE00BFMHRM44.USD","LU1066051225.USD","LU0472753341.HKD","BK4612","LU0158827781.USD","LU0345770308.USD","GOOX","LU2756315318.SGD","LU1778281490.HKD","LU2102340556.USD","IE00B19Z9505.USD","LU1868837300.USD","TRUC","LU0868494617.USD","LU1642822529.SGD","LU1804176565.USD","LU0106261372.USD","LU0107464264.USD","LU0077335932.USD","BK4579","LU1267930730.SGD","BK4550","IE00BMPRXR70.SGD","LU0528227936.USD","LU0096364046.USD","LU1629891620.HKD","LU1032955483.USD","LU0648000940.SGD","LU1823568750.SGD","LU2746668461.USD","LU1400636491.USD","LU0320765489.SGD","GGLS","LU0080751232.USD","LU2505996681.GBP","LU0683600562.USD","LU0820562030.AUD","SG9999014906.USD","LU0708994859.HKD","FCOM","CMAG","LU0157215616.USD","LU0314104364.USD","BK4581","LU0494093205.USD","IE00BLSP4452.SGD","LU1232071149.USD","LU1923623000.USD","LU0057025933.USD","LU1201861249.SGD","IE0002141913.USD","LU1435385759.SGD","SG9999014914.USD","LU1267930573.SGD","LU1303367103.USD","LU2756315664.SGD","LU0310799852.SGD","LU1066053197.SGD","LU2023250843.SGD","BBH","LU0138981039.USD","LU0256863902.USD","LU2125154778.USD","LU0985320562.USD","LU0234570918.USD","LU0345770993.USD","LU1914381329.SGD","LU2430703178.SGD","LU0289739343.SGD","LU1791710400.SGD","BK4566","IE00B2B36J28.USD","IE00BQXX3D17.EUR","LU1084165304.USD","LU1244550221.USD","BK4077","BK4592","LU2065171311.SGD","SG9999015945.SGD","LU1046421795.USD","LU1989772840.SGD","XLC","IE00BK4W5L77.USD","LU0661504455.SGD","LU2403377893.USD","SG9999014898.SGD","LU1894683348.USD","IE00BFTCPJ56.SGD","LU0689472784.USD","LU0353189763.USD","LU1316542783.SGD","LU2097344357.USD","IE00BKVL7J92.USD","GXPC","LU0889566641.SGD","LU2125154935.USD","LU2362541273.HKD","LU0069063385.USD","LU0868494708.USD","LU1989772923.USD","LU2456880835.USD","LU1280957306.USD","LU1323610961.USD","LU2746668974.SGD","LU2750360997.AUD","HK0000914686.HKD","LU1429558221.USD","LU2023251221.USD","LU1670756490.USD","IE00B19Z3B42.SGD","LU1496350171.SGD","LU0187121727.USD","LU0310800965.SGD","LU2065170008.USD","LU2242650005.HKD","LU0345774391.USD","LU0949170426.SGD","LU1244550577.SGD","LU0708995401.HKD","IE0001KFT4U8.USD","LU0302445910.USD","IE00BKDWB100.SGD","GOU","LU1974910355.USD","IE00BJT1NW94.SGD","LU2191332357.HKD","LU1119994496.HKD","EFIV","LU2168564065.EUR","LU2326559502.SGD","LU0964807845.USD","LU2023250330.USD","SG9999015952.SGD","LU2417539215.USD","LU0109394709.USD","LU1839511570.USD","LU2471134523.USD","LU0256863811.USD","LU2750360641.GBP","IE00B7SZLL34.SGD","LU0048584097.USD","LU1064131342.USD","IE00BMPRXQ63.HKD","LU0251142724.SGD","LU0203345920.USD","LU0048573561.USD","LU2491049909.HKD","LU1815336760.USD","SG9999015978.USD","LU0127658192.USD","LU0289961442.SGD","SGXZ51526630.SGD","LU1633808545.USD","IE00B19Z3581.USD","LU1506573853.SGD","LU0143551892.USD","SKYY","LU1202635105.USD","LU1548497426.USD","LU0787776722.HKD","LU2271345857.HKD","LU2491050071.SGD","IE0002270589.USD","LU1366333091.USD","LU0784384876.USD","LU2602419157.SGD","CANC","LU2247934214.USD","LU0276348264.USD","LU1935043023.USD","HK0000914660.USD","LU2462591350.SGD","LU1791710582.SGD","LU0417517546.SGD","BK4139","LU0320765059.SGD","BK4532","LU0820561909.HKD","LU1551013342.USD","LU2491050154.USD","SG9999015986.USD","IE00B19Z8W00.USD","IE00B4R5TH58.HKD","LU1868837136.USD","LU0976567544.SGD","LU2211815571.USD","LU1221951129.SGD","LU0345769631.USD","LU2054465674.USD","LU0174119429.USD","LU0154236417.USD","LU0215105999.USD","LU0314106906.USD","LU0690374961.EUR","LU2362541513.USD","LU0342679015.USD","SNPE","LU0149725797.USD","IDNA","LU2087621335.USD","LU0742534661.SGD","LU1674673428.USD","LU0056508442.USD","LU2471134952.CNY","LU0208291251.USD","LU0251132253.USD","LU2028103732.USD","LU1718418525.SGD","GB00B4QBRK32.GBP","IE00BLSP4239.USD","LU1201861165.SGD","LU0225283273.USD","LTL","LU0130518102.USD","LU1670628061.USD","BK4573","LU1935042488.USD","LU0006306889.USD","BK4576","LU2430703095.HKD","LU1121112475.USD","SG9999014575.USD","LU1116320901.HKD","LU1244550494.USD","LU0251131958.USD","LU0203347892.USD","LU0553294199.USD","LU0316494557.USD","IE0034235303.USD","IE00B1XK9C88.USD","IE00BZ1G4Q59.USD","LU1496350502.SGD","LU2065169927.USD","LU1951200564.SGD","LU0070302665.USD","LU2242649171.HKD","LU1145028129.USD","LU0353189680.USD","IE000MB6IJN5.SGD","LU1923622614.USD","LU0672654240.SGD","LU0320765992.SGD","BK4538","LU1868836757.USD","LU0265550946.USD","LU0211327993.USD","IE0004091025.USD","LU0511384066.AUD","LU1880398554.USD","LU1815333072.USD","LU2168564495.EUR","BK4533","IE00BD6J9T35.USD","LU0994945656.USD","LU2462591277.SGD","LU2077746001.SGD","IE0034235188.USD","LU1917777945.USD","SGXZ99366536.SGD","IE000BZT7R73.USD","LU0882574139.USD","LU2063271972.USD","LU0648001328.SGD","SG9999014559.SGD","LU0175139822.USD","IE00BJLML261.HKD","LU0957808578.USD","LU0070217475.USD","GOOW","LU2360106780.USD","LU0061474705.USD","LU2089283258.USD","LU1670627923.USD","LU2097344431.USD","LU1868836914.USD","LU0170899867.USD","SG9999014880.SGD","LU2404859667.USD","LU0477156797.USD","LU0096362180.USD","LU0130102774.USD","LU1571399168.USD","CQTM","GGLL","HK0000532082.HKD","LU0097036916.USD","IE00BDCRKT87.USD","LU0289960550.SGD","LU0784385170.HKD","IE00BKPKM429.USD","SGXZ81514606.USD","LU2505996509.AUD","LU0061475181.USD","LU0496365809.HKD","IE00B19Z8X17.USD","SG9999014542.SGD","GB00B4LPDJ14.GBP","SGXZ44715902.SGD","LU0128525929.USD","LU0444971666.USD","LU0823421416.USD","LU1935042215.USD","LU0477156953.USD","LU0310800379.SGD","IE00BWXC8680.SGD","LU0640476718.USD","LU1880398471.USD","LU0820561818.USD","BK4585","LU2092937148.SGD","LU1988902786.USD","LU1674673691.USD","ILDR","PTH","IE00BBT3K403.USD","LU1400636657.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}